Languages

  • English

Medical Devices: Industry Business Drivers and Challenges:

Life Science companies have an unenviable challenge in today’s climate to bring certified regulated products to market.

The COVID#19 Pandemic highlighted that we need to be able to react quickly to patient’s immediate needs but make sure their safety and quality of the product are not compromised resulting in maximising the clinician and patient experience.

This discussion focuses on positioning Insilco (virtual testing in CAE) as one way to aid shortening project lifecycle and improve patient’s experience.

What is covered?

  • What are the Life Science industry dynamics today?
  • What are the business drivers and company objectives?
  • How do you improve device quality and reduce patients’ risk?
  • How to improve Patient experience?
  • How do companies balance physical test costs against improving patient experience?
  • Why use simulation within regulatory bodies approvals?
  • What if we can generate defensible evidence in days instead of years?
  • Does Simulation replace physical testing?

Who is it for?

If you are in the Life Science industry you shouldn’t miss this opportunity

What’s coming next?

Engineered to Cure

Register to watch